Vetnews | September 2025 14 « BACK TO CONTENTS Article The vaccine complies with the test if no animal shows adverse reactions or dies of causes attributable to the vaccine.22 7. Serological test In the serological test, ten female SW1 mice, each weighing 13-16 g, are used. Each mouse is vaccinated by an intraperitoneal route using 0.5 mL of 1/5 of the recommended dose volume at days 0 and 7. Blood samples are taken 14 days after the first injection, and the sera are tested individually for IgG, IgM, and TNFα by quantitative enzyme-linked immunosorbent assay.23 8. Potency test In addition to Serological assays, potency was analysed according to the National Institutes of Health (NIH) test recommended by the WHO. Mice were immunised on days 0 and 7 with 0.5 mL/dose of all experimental and reference groups via intraperitoneal (IP). Both the experimental vaccines and the international reference standard rabies vaccine were diluted in a serial 5-fold dilution (1/25, 1/125, 1/625). All mice were then challenged on day 14 via an intracerebral administration (IC) of 30 µL rabies strain CVS11 (Pasteur Institute of Iran, Alborz, Iran) containing 42 LD50. Subsequently, mice were observed for another 14 days, and the mortality of mice was recorded to calculate the ED50 that is normalised with the international reference standard vaccine by using the Spearman–Karber formula to obtain a titer in IU NIH/dose. The Ph. Eur. Biological Reference Preparation (BRP) Batch Number 5 for rabies vaccine (inactivated) for veterinary use (EDQM) was used to calibrate the test. The potency is expressed in International Units/mL (IU/mL).24 9. Statistical analysis Statistical analysis was performed using one-way ANOVA using GraphPad Prism (version 8.0, GraphPad Software, CA, USA), and statistical analyses were performed using SPSS Statistics software version 26.0 (IBM, USA). All titrations were carried out in triplicate, and titers are expressed as mean values±standard deviation (SD). The comparison between groups was considered statistically significant if p<0.05 or 0.001. Furthermore, receiver operating characteristic (ROC) curves were utilised to evaluate the sensitivity and specificity of the diagnostic test, while multivariable logistic regression analysis was employed to examine the association between the predictor variables and the outcome variable. RESULTS 1. IgG and IgM assay As shown in Fig. 1A, mice immunized with the conjugate of inactivated rabies virus and oxidized mannan (Rab-OxMan) exhibited a significantly higher IgG titer (12.09±0.94 mg/mL) compared to those receiving mannan (Rab-Man) (11.01±0.65 mg/mL) and the Alumadjuvanted inactivated rabies vaccine (Rab-Al) (7.94±0.71 mg/mL), with a p-value of less than 0.05 indicating statistical significance. The elevated IgG response is promising, as higher IgG levels are often correlated with enhanced protection and long-term immunity against pathogens. Conversely, as illustrated in Fig. 1B, the Rab-OxMan group showed a significantly lower IgM titer (0.54±0.05 mg/mL) than both the Rab-Man (1.03±0.10 mg/mL) and Rab-Al groups (0.72±0.07 mg/mL), with p-values<0.05. This reduction in IgM, while statistically significant, suggests a potential trade-off, as IgM is typically the first antibody produced in response to infection, reflecting early immune activation. These results indicate that although the Rab-OxMan formulation effectively induces a stronger IgG response, which is beneficial for longterm efficacy, it is associated with a reduced IgM response compared to other vaccine formulations. Further investigations are needed to evaluate the longevity of the IgG response and its correlation with long-term protection, as well as to understand the implications of the lower IgM response in the context of overall vaccine efficacy. 2. TNF-α assay In this assay, serum levels of TNFαmeasured by ELISA, were significantly higher in mice vaccinated with Rab-OxMan (47.67±13.1 pg/mL) compared to those immunised with Rab-Man (27.0±8.7 pg/mL) and Rab-Al (24.33±6.2 pg/mL), p<0.05. These results, depicted in Fig. 2, demonstrate that immunisation with the RabOxMan vaccine leads to an increased TNF-α level compared to the other groups, highlighting its potential effectiveness in eliciting a robust immune response. 3. Sensitivity and specificity analysis of the variables The specificity and sensitivity of the sera IgG, IgM and TNF-α levels were assessed using a receiver operating characteristic (ROC) curve. Areas under the curve (AUCs) and p-values were obtained as AUC=0.895 and p<0.001 for IgG, AUC=0.827 and p<0.001 for IgM, and AUC=0.752 and p<0.001 for TNF-α (Fig. 3). According to the results, the sera IgG levels demonstrated the highest sensitivity and specificity compared with other variables. Oxidised Mannan..... <<< 13
RkJQdWJsaXNoZXIy OTc5MDU=